更多...
收起
The dynamic modification of cytoplasmic and nuclear proteins by O-linked N-acetylglucosamine (O-GlcNAc) addition and removal on serine and threonine residues is catalyzed by OGT (MIM 300255), which adds O-GlcNAc, and MGEA5, a glycosidase that removes O-GlcNAc modifications (Gao et al., 2001 [PubMed 11148210]).[supplied by OMIM, Mar 2008]
[中文简述(自动翻译):]  按O连接的N-乙酰细胞质和细胞核蛋白的动态修改(O-GlcNAc的)添加和删除的丝氨酸和苏氨酸残基被OGT催化(MIM 300255),它增加了O型N-乙酰葡糖胺和MGEA5,糖苷酶,消除O型的GlcNAc修饰(Gao等,2001 [考研11148210])。[由OMIM,2008年3月供应]
MGEA5基因(以及对应的蛋白质)的细胞分布位置:
MGEA5基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Reperfusion Injury | 0.08 | 1 | 0 | RGD |
| Tay-Sachs Disease | 0.016829396 | 62 | 0 | BeFree |
| Sandhoff Disease | 0.008143256 | 30 | 0 | BeFree |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.005905708 | 3 | 0 | BeFree_GAD_LHGDN |
| Lysosomal Storage Diseases | 0.002985861 | 11 | 0 | BeFree |
| Gangliosidoses, GM2 | 0.002171535 | 8 | 0 | BeFree |
| Motor Neuron Disease | 0.001357209 | 5 | 0 | BeFree |
| Neurodegenerative Disorders | 0.001357209 | 5 | 0 | BeFree |
| Myxoinflammatory fibroblastic sarcoma | 0.001085767 | 4 | 0 | BeFree |
| Diabetes | 0.000814326 | 3 | 0 | BeFree |
| Diabetes Mellitus | 0.000814326 | 3 | 0 | BeFree |
| Gangliosidoses | 0.000814326 | 3 | 0 | BeFree |
| Alzheimer's Disease | 0.000542884 | 2 | 0 | BeFree |
| Gaucher Disease | 0.000542884 | 2 | 0 | BeFree |
| Hypertensive disease | 0.000542884 | 2 | 0 | BeFree |
| Kidney Diseases | 0.000542884 | 2 | 0 | BeFree |
| Obesity | 0.000542884 | 2 | 0 | BeFree |
| Infantile Sandhoff Disease | 0.000542884 | 2 | 0 | BeFree |
| Juvenile Sandhoff Disease | 0.000542884 | 2 | 0 | BeFree |
| Pleomorphic hyalinizing angiectatic tumor | 0.000542884 | 2 | 0 | BeFree |
| Aortic Valve Stenosis | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of breast | 0.000271442 | 1 | 0 | BeFree |
| Colorectal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Encephalitis | 0.000271442 | 1 | 0 | BeFree |
| Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
| Heart failure | 0.000271442 | 1 | 0 | BeFree |
| Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
| Type II Mucolipidosis | 0.000271442 | 1 | 0 | BeFree |
| Meningioma | 0.000271442 | 1 | 0 | BeFree |
| Mucopolysaccharidoses | 0.000271442 | 1 | 0 | BeFree |
| Myocardial Infarction | 0.000271442 | 1 | 0 | BeFree |
| Panic Disorder | 0.000271442 | 1 | 0 | BeFree |
| Parkinson Disease | 0.000271442 | 1 | 0 | BeFree |
| Pseudo-Hurler Polydystrophy | 0.000271442 | 1 | 0 | BeFree |
| Sphingolipidoses | 0.000271442 | 1 | 0 | BeFree |
| Mucopolysaccharidosis Type IIIA | 0.000271442 | 1 | 0 | BeFree |
| Memory impairment | 0.000271442 | 1 | 0 | BeFree |
| Tay-Sachs Disease, AB Variant | 0.000271442 | 1 | 0 | BeFree |
| Impaired glucose tolerance | 0.000271442 | 1 | 0 | BeFree |
| Senile Plaques | 0.000271442 | 1 | 0 | BeFree |
| Impaired cognition | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of prostate | 0.000271442 | 1 | 0 | BeFree |
| Prostate carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.000271442 | 1 | 0 | BeFree |
| Microalbuminuria | 0.000271442 | 1 | 0 | BeFree |
| Anaphylaxis (non medication) | 0.000271442 | 1 | 0 | BeFree |
| Diabetic Cardiomyopathies | 0.000271442 | 1 | 0 | BeFree |
| Post MI | 0.000271442 | 1 | 0 | BeFree |
| Renal ischaemia | 0.000271442 | 1 | 0 | BeFree |
| Colorectal cancer metastatic | 0.000271442 | 1 | 0 | BeFree |
| Sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Colorectal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Meningioma, benign, no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
| Hexosaminidase alpha-Subunit Deficiency (Variant B) | 0.000271442 | 1 | 0 | BeFree |
| PANIC DISORDER 1 | 0.000271442 | 1 | 0 | BeFree |
| Plaque, Amyloid | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。